5 Biotechs Awaiting FDA Decisions in January 2018 Post author:Sam Post published:December 27, 2017 Post category:BioPharma From 1997 through 2013, there was an average of 27 novel drugs approved in the U.S. per year. Source: BioSpace You Might Also Like 3 Sizzling Hot Biotech Stocks Only Likely to Get Hotter July 20, 2017 Why June Could be a Pivotal Month for These 2 Biotechs May 29, 2017 Trevena Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) May 31, 2017